Key result
Serum omentin levels were positively associated with insulin sensitivity and HDL cholesterol, and inversely associated with BMI and triglycerides, which was mediated by adiponectin.
Cross-Sectional (n=1,092)
In a large population-based cohort, circulating omentin levels were associated with insulin sensitivity, an effect that appears to be mediated by adiponectin.
Answers are grounded in this paper and cite their sources.
Omentin-adiponectin axis may mark insulin sensitivity; hypothesis-generating and should not yet change practice.
OBJECTIVE: Reduced circulating omentin levels have been reported in obesity and type 2 diabetes, but data were mostly derived from univariate analyses in small study samples. This study aimed to investigate the relationship between omentin, abnormal glucose tolerance and related metabolic factors in a large population-based cross-sectional study. DESIGN AND METHODS: Serum omentin was measured by ELISA in 1092 participants of the German KORA F4 survey (2006-2008). Associations between omentin serum levels, glucose tolerance (assessed with an oral glucose tolerance test) and diabetes-related factors were estimated using logistic and linear regression models respectively. RESULTS: Serum levels of omentin were not related to categories of glucose tolerance. However, serum omentin was positively associated with whole-body insulin sensitivity index (ISI (composite)) and HDL cholesterol and showed inverse associations with 2-h post-load glucose, fasting insulin, homeostasis model assessment-estimated insulin resistance, BMI and triglycerides (all P≤0.03 after adjustment for age, sex and lifestyle factors). Further adjustment for BMI and/or serum lipids attenuated the associations with parameters of glucose metabolism, whereas adjustment for serum adiponectin virtually abolished all aforementioned associations. In contrast, adjustment for omentin had no effect on the positive association between adiponectin levels and ISI (composite). CONCLUSIONS: The data from this large population-based cohort show that circulating omentin levels are associated with insulin sensitivity. Our observations further suggest that omentin acts via upregulation of adiponectin, which in turn affects lipid metabolism and thereby also indirectly enhances insulin sensitivity, but mechanistic studies are required to corroborate this hypothesis.
No takes yet. Share an insight, caveat, or question.
Herder et al. (2015) conducted a cross-sectional in Abnormal glucose tolerance and related metabolic factors (n=1,092). Serum omentin levels was evaluated on Glucose tolerance and diabetes-related factors (insulin sensitivity, lipids) (p=≤0.03). Serum omentin levels were positively associated with insulin sensitivity and HDL cholesterol, and inversely associated with BMI and triglycerides, which was mediated by adiponectin.
Synapse has enriched 10 related papers. Consider them for comparative context: